Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ganapathi

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposideL A Hammond, J R Eckardt, R Ganapathi, et al.
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposideL A Hammond, J R Eckardt, R Ganapathi, et al.
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Pageof 14